Symbols / LFST Stock $7.67 +5.50% LifeStance Health Group, Inc.

Healthcare • Medical Care Facilities • United States • NMS
LFST (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Mr. David Patrick Bourdon
Exch · Country NMS · United States
Market Cap 2.97B
Enterprise Value 3.22B
Income 9.66M
Sales 1.42B
FCF (ttm) 112.90M
Book/sh 3.92
Cash/sh 0.64
Employees 10,961
Insider 10d —
IPO Jun 10, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 383.50
Forward P/E 20.06
PEG —
P/S 2.09
P/B 1.96
P/C —
EV/EBITDA 40.23
EV/Sales 2.26
Quick Ratio 1.38
Current Ratio 1.65
Debt/Eq 31.20
LT Debt/Eq —
EPS (ttm) 0.02
EPS next Y 0.38
EPS Growth —
Revenue Growth 17.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-25
ROA 0.73%
ROE 0.65%
ROIC —
Gross Margin 32.37%
Oper. Margin 4.74%
Profit Margin 0.68%
Shs Outstand 387.83M
Shs Float 204.89M
Insider Own 4.59%
Instit Own 90.24%
Short Float 3.45%
Short Ratio 3.59
Short Interest 6.57M
52W High 8.09
vs 52W High -5.19%
52W Low 3.74
vs 52W Low 105.08%
Beta 1.13
Impl. Vol. 28.13%
Rel Volume 3.31
Avg Volume 2.34M
Volume 7.74M
Target (mean) $9.83
Tgt Median $10.00
Tgt Low $8.00
Tgt High $12.00
# Analysts 9
Recom Strong_buy
Prev Close $7.27
Price $7.67
Change 5.50%
About

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$9.83
Mean price target
2. Current target
$7.67
Latest analyst target
3. DCF / Fair value
$5.24
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$7.67
Low
$8.00
High
$12.00
Mean
$9.83

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-06 main Barclays Overweight → Overweight $9
2026-02-26 main Canaccord Genuity Buy → Buy $10
2026-02-26 main UBS Buy → Buy $12
2026-02-26 main Keybanc Overweight → Overweight $9
2026-02-02 main BTIG Buy → Buy $11
2025-12-12 main BTIG Buy → Buy $10
2025-12-09 init Barclays — → Overweight $8
2025-11-13 init BMO Capital — → Outperform $8
2025-11-07 main UBS Buy → Buy $10
2025-11-06 main BTIG Buy → Buy $9
2025-08-08 main UBS Buy → Buy $9
2025-05-27 up UBS Neutral → Buy $9
2025-04-08 init Keybanc — → Overweight $9
2025-04-03 init Canaccord Genuity — → Buy $8
2024-12-16 up Goldman Sachs Neutral → Buy $10
2024-11-11 main Barclays Underweight → Underweight $7
2024-08-15 main UBS Neutral → Neutral $8
2024-08-09 main Barclays Underweight → Underweight $6
2024-04-22 reit Morgan Stanley Overweight → Overweight $10
2024-03-06 main Jefferies Buy → Buy $9
News
RSS: Latest LFST news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-24 BESSLER ROBERT Director — 69,899 $7.00 $492,400
2026-04-21 BESSLER ROBERT Director — 5,101 $7.01 $35,758
2026-03-09 PAUNOVICH VUKASIN Chief Technology Officer — 62,935 $0.00 $0
2026-03-09 VARANAKIS ANN Officer — 86,625 $0.00 $0
2026-03-09 MILLER LISA K Chief Operating Officer — 26,836 $0.00 $0
2026-03-09 MCGROARTY RYAN Chief Financial Officer — 193,046 $0.00 $0
2026-03-09 BURDICK KENNETH A Director — 740,504 $0.00 $0
2026-03-09 BOURDON DAVID Chief Executive Officer — 328,544 $0.00 $0
2026-03-09 PARDO RYAN Officer and Director — 145,965 $0.00 $0
2026-03-05 PAUNOVICH VUKASIN Chief Technology Officer — 86,331 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,424.29
+13.85%
1,250.97
+18.50%
1,055.66
+22.82%
859.54
Operating Revenue
1,424.29
+13.85%
1,250.97
+18.50%
1,055.66
+22.82%
859.54
Cost Of Revenue
963.19
+13.51%
848.57
+12.61%
753.57
+21.05%
622.52
Reconciled Cost Of Revenue
963.19
+13.51%
848.57
+12.61%
753.57
+21.05%
622.52
Gross Profit
461.10
+14.59%
402.40
+33.20%
302.10
+27.46%
237.02
Operating Expense
436.95
+0.68%
434.01
-11.65%
491.23
+9.85%
447.19
Selling General And Administration
382.20
+5.27%
363.06
-11.62%
410.79
+8.68%
377.99
General And Administrative Expense
382.20
+5.27%
363.06
-11.62%
410.79
+8.68%
377.99
Other Gand A
382.20
+5.27%
363.06
-11.62%
410.79
+8.68%
377.99
Total Expenses
1,400.14
+9.17%
1,282.58
+3.04%
1,244.80
+16.37%
1,069.72
Operating Income
24.15
+176.39%
-31.61
+83.29%
-189.13
+10.01%
-210.17
Total Operating Income As Reported
24.15
+176.39%
-31.61
+83.29%
-189.13
+10.01%
-210.17
EBITDA
78.78
+97.58%
39.87
+138.00%
-104.93
+26.93%
-143.60
Normalized EBITDA
78.78
+102.13%
38.97
+135.82%
-108.81
+22.94%
-141.19
Reconciled Depreciation
54.75
-22.83%
70.95
-11.79%
80.44
+16.24%
69.20
EBIT
24.02
+177.31%
-31.08
+83.23%
-185.36
+12.89%
-212.80
Total Unusual Items
0.00
-100.00%
0.90
-76.87%
3.88
+261.12%
-2.41
Total Unusual Items Excluding Goodwill
0.00
-100.00%
0.90
-76.87%
3.88
+261.12%
-2.41
Special Income Charges
0.00
-100.00%
0.90
-76.87%
3.88
+261.12%
-2.41
Restructuring And Mergern Acquisition
0.00
+100.00%
-0.90
+76.87%
-3.88
-261.12%
2.41
Net Income
9.66
+116.82%
-57.44
+69.16%
-186.26
+13.59%
-215.56
Pretax Income
12.36
+121.46%
-57.61
+72.11%
-206.58
+11.23%
-232.73
Net Non Operating Interest Income Expense
-11.66
+56.05%
-26.54
-25.05%
-21.22
-6.48%
-19.93
Interest Expense Non Operating
11.66
-56.05%
26.54
+25.05%
21.22
+6.48%
19.93
Net Interest Income
-11.66
+56.05%
-26.54
-25.05%
-21.22
-6.48%
-19.93
Interest Expense
11.66
-56.05%
26.54
+25.05%
21.22
+6.48%
19.93
Other Income Expense
-0.12
-122.99%
0.54
-85.81%
3.77
+243.49%
-2.63
Other Non Operating Income Expenses
-0.12
+66.12%
-0.36
-224.11%
-0.11
+48.62%
-0.22
Tax Provision
2.70
+1688.24%
-0.17
+99.16%
-20.32
-18.38%
-17.17
Tax Rate For Calcs
0.00
+7166.67%
0.00
-96.94%
0.00
+32.43%
0.00
Tax Effect Of Unusual Items
0.00
-100.00%
0.00
-99.29%
0.38
+313.38%
-0.18
Net Income Including Noncontrolling Interests
9.66
+116.82%
-57.44
+69.16%
-186.26
+13.59%
-215.56
Net Income From Continuing Operation Net Minority Interest
9.66
+116.82%
-57.44
+69.16%
-186.26
+13.59%
-215.56
Net Income From Continuing And Discontinued Operation
9.66
+116.82%
-57.44
+69.16%
-186.26
+13.59%
-215.56
Net Income Continuous Operations
9.66
+116.82%
-57.44
+69.16%
-186.26
+13.59%
-215.56
Normalized Income
9.66
+116.56%
-58.34
+69.26%
-189.76
+11.05%
-213.33
Net Income Common Stockholders
9.66
+116.82%
-57.44
+69.16%
-186.26
+13.59%
-215.56
Otherunder Preferred Stock Dividend
—
—
0.00
0.00
Diluted EPS
0.02
+113.33%
-0.15
+70.59%
-0.51
+16.39%
-0.61
Basic EPS
0.03
+120.00%
-0.15
+70.59%
-0.51
+16.39%
-0.61
Basic Average Shares
386.02
+1.81%
379.15
+3.18%
367.46
+3.43%
355.28
Diluted Average Shares
391.14
+3.16%
379.15
+3.18%
367.46
+3.43%
355.28
Diluted NI Availto Com Stockholders
9.66
+116.82%
-57.44
+69.16%
-186.26
+13.59%
-215.56
Depreciation Amortization Depletion Income Statement
54.75
-22.83%
70.95
-11.79%
80.44
+16.24%
69.20
Depreciation And Amortization In Income Statement
54.75
-22.83%
70.95
-11.79%
80.44
+16.24%
69.20
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
2,203.93
+4.04%
2,118.30
+0.39%
2,109.97
-2.94%
2,173.87
Current Assets
416.20
+33.18%
312.51
+38.44%
225.73
-3.21%
233.22
Cash Cash Equivalents And Short Term Investments
248.64
+60.86%
154.57
+96.10%
78.82
-27.43%
108.62
Cash And Cash Equivalents
248.64
+60.86%
154.57
+96.10%
78.82
-27.43%
108.62
Receivables
99.50
-24.64%
132.03
+5.08%
125.64
+23.77%
101.51
Accounts Receivable
95.71
-27.38%
131.80
+5.10%
125.41
+24.33%
100.87
Other Receivables
3.79
+1599.55%
0.22
-5.11%
0.23
-63.28%
0.64
Prepaid Assets
48.13
+337.11%
11.01
+4.49%
10.54
-12.89%
12.10
Other Current Assets
19.93
+33.72%
14.90
+38.90%
10.73
-2.44%
11.00
Total Non Current Assets
1,787.73
-1.00%
1,805.79
-4.16%
1,884.24
-2.91%
1,940.65
Net PPE
311.30
-0.83%
313.92
-12.54%
358.93
-8.81%
393.62
Gross PPE
443.38
+6.63%
415.79
-2.76%
427.61
-2.04%
436.50
Accumulated Depreciation
-132.07
-29.65%
-101.87
-48.32%
-68.68
-60.17%
-42.88
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
84.55
+4.65%
80.79
+5.18%
76.81
+8.22%
70.98
Construction In Progress
13.38
+69.93%
7.87
-12.87%
9.04
-46.50%
16.89
Other Properties
150.79
+1.39%
148.72
-13.31%
171.54
-14.39%
200.38
Leases
194.65
+9.11%
178.41
+4.81%
170.21
+14.81%
148.25
Goodwill And Other Intangible Assets
1,471.01
-0.88%
1,484.14
-2.00%
1,514.42
-1.42%
1,536.23
Goodwill
1,293.35
+0.00%
1,293.35
+0.00%
1,293.35
+1.60%
1,272.94
Other Intangible Assets
177.66
-6.88%
190.80
-13.69%
221.07
-16.04%
263.29
Non Current Prepaid Assets
—
—
—
—
Other Non Current Assets
5.42
-29.84%
7.72
-29.11%
10.89
+0.93%
10.79
Total Liabilities Net Minority Interest
682.92
+1.62%
672.01
-1.33%
681.04
+3.95%
655.15
Current Liabilities
251.96
+10.08%
228.89
+12.82%
202.87
+15.27%
176.00
Payables And Accrued Expenses
191.64
+11.65%
171.65
+18.75%
144.54
+22.12%
118.36
Payables
18.85
-26.57%
25.68
+10.63%
23.21
-4.76%
24.37
Accounts Payable
18.85
-26.57%
25.68
+10.63%
23.21
-4.76%
24.37
Other Payable
—
—
—
—
Current Accrued Expenses
172.78
+18.37%
145.97
+20.31%
121.33
+29.09%
93.99
Current Debt And Capital Lease Obligation
60.04
+5.90%
56.70
+14.78%
49.40
+27.24%
38.82
Current Debt
14.50
+100.00%
7.25
+147.86%
2.92
+24.73%
2.35
Other Current Borrowings
14.50
+100.00%
7.25
+147.86%
2.92
+24.73%
2.35
Current Capital Lease Obligation
45.54
-7.90%
49.45
+6.40%
46.48
+19.71%
38.82
Other Current Liabilities
0.28
-47.97%
0.54
-93.93%
8.93
-52.52%
18.81
Total Non Current Liabilities Net Minority Interest
430.96
-2.75%
443.13
-7.33%
478.17
-0.21%
479.15
Long Term Debt And Capital Lease Obligation
414.48
-3.27%
428.49
-7.18%
461.64
+5.48%
437.67
Long Term Debt
265.93
-4.95%
279.79
-0.18%
280.29
+24.53%
225.08
Long Term Capital Lease Obligation
148.55
-0.10%
148.70
-18.01%
181.36
-14.69%
212.59
Non Current Deferred Liabilities
16.41
+14.51%
14.33
-7.98%
15.57
-59.76%
38.70
Non Current Deferred Taxes Liabilities
16.41
+14.51%
14.33
-7.98%
15.57
-59.76%
38.70
Other Non Current Liabilities
0.07
-77.99%
0.31
-67.54%
0.95
-65.79%
2.78
Preferred Securities Outside Stock Equity
—
—
—
—
Stockholders Equity
1,521.02
+5.17%
1,446.29
+1.21%
1,428.93
-5.91%
1,518.72
Common Stock Equity
1,521.02
+5.17%
1,446.29
+1.21%
1,428.93
-5.91%
1,518.72
Capital Stock
3.88
+1.46%
3.83
+1.00%
3.79
+0.74%
3.76
Common Stock
3.88
+1.46%
3.83
+1.00%
3.79
+0.74%
3.76
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
388.32
+1.46%
382.74
+1.06%
378.73
+0.73%
375.96
Ordinary Shares Number
388.32
+1.46%
382.74
+1.06%
378.73
+0.73%
375.96
Additional Paid In Capital
2,325.76
+2.92%
2,259.82
+3.49%
2,183.68
+4.77%
2,084.32
Retained Earnings
-808.63
+1.18%
-818.29
-7.55%
-760.85
-32.87%
-572.64
Gains Losses Not Affecting Retained Earnings
0.00
-100.00%
0.93
-59.66%
2.30
-29.66%
3.27
Other Equity Adjustments
—
0.93
-59.66%
2.30
-29.66%
3.27
Total Equity Gross Minority Interest
1,521.02
+5.17%
1,446.29
+1.21%
1,428.93
-5.91%
1,518.72
Total Capitalization
1,786.94
+3.53%
1,726.08
+0.99%
1,709.21
-1.98%
1,743.80
Working Capital
164.24
+96.40%
83.62
+265.84%
22.86
-60.06%
57.22
Invested Capital
1,801.44
+3.93%
1,733.33
+1.24%
1,712.14
-1.82%
1,743.80
Total Debt
474.52
-2.20%
485.19
-5.06%
511.04
+7.25%
476.49
Net Debt
31.79
-76.01%
132.47
-35.19%
204.39
+75.50%
116.46
Capital Lease Obligations
194.10
-2.04%
198.15
-13.03%
227.83
-9.38%
251.41
Net Tangible Assets
50.00
+232.08%
-37.86
+55.71%
-85.49
-388.22%
-17.51
Tangible Book Value
50.00
+232.08%
-37.86
+55.71%
-85.49
-388.22%
-17.51
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
146.15
+36.26%
107.26
+735.28%
-16.88
-131.98%
52.79
Cash Flow From Continuing Operating Activities
146.15
+36.26%
107.26
+735.28%
-16.88
-131.98%
52.79
Net Income From Continuing Operations
9.66
+116.82%
-57.44
+69.16%
-186.26
+13.59%
-215.56
Depreciation Amortization Depletion
54.75
-22.83%
70.95
-11.79%
80.44
+16.24%
69.20
Depreciation
41.62
+2.32%
40.68
+8.84%
37.37
+29.23%
28.92
Amortization Cash Flow
13.13
-56.61%
30.27
-29.70%
43.06
+6.91%
40.28
Depreciation And Amortization
54.75
-22.83%
70.95
-11.79%
80.44
+16.24%
69.20
Amortization Of Intangibles
13.13
-56.61%
30.27
-29.70%
43.06
+6.91%
40.28
Other Non Cash Items
44.96
+9.99%
40.87
-9.56%
45.20
+7.57%
42.02
Stock Based Compensation
74.70
-1.93%
76.17
-23.36%
99.39
-46.97%
187.43
Deferred Tax
2.42
+352.82%
-0.96
+95.63%
-21.92
-31.00%
-16.73
Deferred Income Tax
2.42
+352.82%
-0.96
+95.63%
-21.92
-31.00%
-16.73
Operating Gains Losses
—
5.03
—
3.38
Change In Working Capital
-40.34
-47.42%
-27.37
+18.85%
-33.72
-99.10%
-16.94
Change In Receivables
36.09
+664.20%
-6.40
+73.54%
-24.18
-11.60%
-21.66
Changes In Account Receivables
36.09
+664.20%
-6.40
+73.54%
-24.18
-11.60%
-21.66
Change In Prepaid Assets
-46.69
-1301.11%
-3.33
-8.53%
-3.07
+10.52%
-3.43
Change In Payables And Accrued Expense
18.38
-36.87%
29.11
-6.36%
31.09
+45.77%
21.32
Change In Accrued Expense
19.94
-30.30%
28.61
-22.03%
36.69
+168.64%
13.66
Change In Payable
-1.56
-411.98%
0.50
+108.94%
-5.61
-173.11%
7.67
Change In Account Payable
-1.56
-411.98%
0.50
+108.94%
-5.61
-173.11%
7.67
Change In Other Current Liabilities
-48.13
-2.95%
-46.75
-24.45%
-37.56
-185.25%
-13.17
Investing Cash Flow
-36.12
-67.51%
-21.57
+64.26%
-60.34
+56.73%
-139.46
Cash Flow From Continuing Investing Activities
-36.12
-67.51%
-21.57
+64.26%
-60.34
+56.73%
-139.46
Net PPE Purchase And Sale
-36.12
-67.51%
-21.57
+46.78%
-40.52
+48.87%
-79.25
Purchase Of PPE
-36.12
-67.51%
-21.57
+46.78%
-40.52
+48.87%
-79.25
Capital Expenditure
-36.12
-67.51%
-21.57
+46.78%
-40.52
+48.87%
-79.25
Net Business Purchase And Sale
0.00
0.00
+100.00%
-19.82
+67.08%
-60.21
Purchase Of Business
0.00
0.00
+100.00%
-19.82
+67.08%
-60.21
Financing Cash Flow
-15.96
-60.40%
-9.95
-120.97%
47.43
+0.34%
47.26
Cash Flow From Continuing Financing Activities
-15.96
-60.40%
-9.95
-120.97%
47.43
+0.34%
47.26
Net Issuance Payments Of Debt
-7.25
-330.27%
-1.69
-103.05%
55.28
-20.52%
69.56
Issuance Of Debt
0.00
-100.00%
287.81
+398.34%
57.75
-77.56%
257.32
Repayment Of Debt
-7.25
+97.50%
-289.49
-11620.40%
-2.47
+98.68%
-187.77
Long Term Debt Issuance
0.00
-100.00%
287.81
+398.34%
57.75
-77.56%
257.32
Long Term Debt Payments
-7.25
+97.50%
-289.49
-11620.40%
-2.47
+98.68%
-187.77
Net Long Term Debt Issuance
-7.25
-330.27%
-1.69
-103.05%
55.28
-20.52%
69.56
Net Common Stock Issuance
—
—
0.00
0.00
Repurchase Of Capital Stock
—
—
—
0.00
Net Other Financing Charges
-8.71
-5.36%
-8.26
-5.17%
-7.86
+64.76%
-22.29
Changes In Cash
94.07
+24.19%
75.75
+354.21%
-29.80
+24.39%
-39.41
Beginning Cash Position
154.57
+96.10%
78.82
-27.43%
108.62
-26.62%
148.03
End Cash Position
248.64
+60.86%
154.57
+96.10%
78.82
-27.43%
108.62
Free Cash Flow
110.03
+28.39%
85.69
+249.28%
-57.40
-116.90%
-26.47
Interest Paid Supplemental Data
17.80
-28.78%
24.99
+18.76%
21.04
+46.49%
14.37
Income Tax Paid Supplemental Data
1.57
+2661.40%
0.06
-28.75%
0.08
-96.42%
2.24
Common Stock Issuance
—
—
0.00
0.00
Issuance Of Capital Stock
—
—
0.00
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Payments
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category